Cost of Revenue

$1.44B

TTM · Period ending: Jun 30, 2026 · USD

EW Cost of Revenue

Latest reported$1.44Bperiod endingJun 30, 2026

EW TTM Cost of Revenue ($436.20M → $1.44B)

TTM cost of revenue

High-resolution chart · PNG

EW cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	1,435,700,000
Mar 31, 2026	1,387,700,000
Dec 31, 2025	1,330,000,000
Sep 30, 2025	1,281,600,000
Jun 30, 2025	1,199,300,000
Mar 31, 2025	1,154,500,000
Dec 31, 2024	1,142,200,000
Sep 30, 2024	1,101,000,000
Jun 30, 2024	1,110,300,000
Mar 31, 2024	1,083,300,000
Dec 31, 2023	1,153,300,000
Sep 30, 2023	1,197,900,000
Jun 30, 2023	1,206,600,000
Mar 31, 2023	1,221,500,000
Dec 31, 2022	1,168,800,000
Sep 30, 2022	1,184,300,000
Jun 30, 2022	1,204,300,000
Mar 31, 2022	1,244,600,000
Dec 31, 2021	1,225,900,000
Sep 30, 2021	1,209,800,000
Jun 30, 2021	1,195,800,000
Mar 31, 2021	1,115,700,000
Dec 31, 2020	1,099,000,000
Sep 30, 2020	1,099,400,000
Jun 30, 2020	1,117,700,000
Mar 31, 2020	1,187,100,000
Dec 31, 2019	1,155,300,000
Sep 30, 2019	1,096,100,000
Jun 30, 2019	1,011,200,000
Mar 31, 2019	929,400,000
Dec 31, 2018	922,100,000
Sep 30, 2018	921,000,000
Jun 30, 2018	917,100,000
Mar 31, 2018	892,500,000
Dec 31, 2017	878,500,000
Sep 30, 2017	853,700,000
Jun 30, 2017	835,400,000
Mar 31, 2017	829,000,000
Dec 31, 2016	791,200,000
Sep 30, 2016	756,800,000
Jun 30, 2016	705,400,000
Mar 31, 2016	661,500,000
Dec 31, 2015	617,200,000
Sep 30, 2015	601,700,000
Jun 30, 2015	623,100,000
Mar 31, 2015	615,700,000
Dec 31, 2014	625,600,000
Sep 30, 2014	610,700,000
Jun 30, 2014	572,300,000
Mar 31, 2014	546,100,000
Dec 31, 2013	522,400,000
Sep 30, 2013	502,700,000
Jun 30, 2013	484,700,000
Mar 31, 2013	489,500,000
Dec 31, 2012	494,600,000
Sep 30, 2012	488,400,000
Jun 30, 2012	502,300,000
Mar 31, 2012	500,300,000
Dec 31, 2011	489,800,000
Sep 30, 2011	483,700,000
Jun 30, 2011	453,900,000
Mar 31, 2011	426,500,000
Dec 31, 2010	408,300,000
Sep 30, 2010	396,500,000
Jun 30, 2010	399,200,000
Mar 31, 2010	400,700,000
Dec 31, 2009	399,100,000
Sep 30, 2009	396,200,000
Jun 30, 2009	402,600,000
Mar 31, 2009	413,700,000
Dec 31, 2008	419,600,000
Sep 30, 2008	420,400,000
Jun 30, 2008	406,200,000
Mar 31, 2008	387,900,000
Dec 31, 2007	378,200,000
Sep 30, 2007	376,000,000
Jun 30, 2007	372,700,000
Mar 31, 2007	373,700,000
Dec 31, 2006	373,500,000
Sep 30, 2006	365,700,000
Jun 30, 2006	369,200,000
Mar 31, 2006	371,400,000
Dec 31, 2005	374,600,000
Sep 30, 2005	376,200,000
Jun 30, 2005	373,200,000
Mar 31, 2005	367,700,000
Dec 31, 2004	370,200,000
Sep 30, 2004	372,800,000
Jun 30, 2004	371,800,000
Mar 31, 2004	369,000,000
Dec 31, 2003	359,400,000
Sep 30, 2003	351,300,000
Jun 30, 2003	334,300,000
Mar 31, 2003	319,100,000
Dec 31, 2002	299,100,000
Sep 30, 2002	281,600,000
Jun 30, 2002	276,100,000
Mar 31, 2002	296,900,000
Dec 31, 2001	324,000,000
Sep 30, 2001	398,400,000